Invivyd
IVVD
75 hedge funds and large institutions have $274M invested in Invivyd in 2022 Q1 according to their latest regulatory filings, with 18 funds opening new positions, 32 increasing their positions, 15 reducing their positions, and 23 closing their positions.
121% more call options, than puts
Call options by funds: $2.41M | Put options by funds: $1.09M
113% more repeat investments, than reductions
Existing positions increased: 32 | Existing positions reduced: 15
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
0.66% less ownership
Funds ownership: 53.93% → 53.27% (-0.66%)
6% less funds holding
Funds holding: 80 → 75 (-5)
22% less first-time investments, than exits
New positions opened: 18 | Existing positions closed: 23
37% less capital invested
Capital invested by funds: $432M → $274M (-$158M)
Top Buyers
| 1 |
Vanguard Group
Malvern,
Pennsylvania
|
+$23.2M |
| 2 |
6CM
683 Capital Management
New York
|
+$10.6M |
| 3 |
BlackRock
New York
|
+$10.1M |
| 4 |
AG
Artal Group
Luxembourg
|
+$6.12M |
| 5 |
TP
Third Point
New York
|
+$6.04M |
Top Sellers
IVVD Hedge Fund Activity: Q1 2022 in Review
75 of the 6,340 institutional investors tracked by Wall St. Rank reported a position in Invivyd (IVVD) for Q1 2022, worth a combined $274M — down 37% from $432M a quarter earlier.
Sellers outnumbered buyers: 23 funds closed out of IVVD and 18 opened new positions — a net loss of 5 holders — while 15 trimmed existing stakes and 32 added.
The largest buyer was Vanguard Group, adding an estimated $23.2M. The largest seller was RA Capital Management, exiting entirely with an estimated $36.3M sold.
- 75 institutional investors held Invivyd (IVVD) as of Q1 2022, down from 80 in Q4 2021.
- Funds reported $274M of Invivyd stock for Q1 2022, down 37% quarter-over-quarter.
- 18 funds opened new Invivyd positions in Q1 2022 and 23 closed out, a net change of -5 holders.
- The largest Invivyd buyer in Q1 2022 was Vanguard Group, an estimated $23.2M added.
- The largest Invivyd seller in Q1 2022 was RA Capital Management, an estimated $36.3M sold.
Based on aggregated 13F filings for Q1 2022.